Questions for PP Talks – Covid-19 & Children

1. Rationale?

a. Symptoms less severe than in adults

b. Children may carry the virus w/o S/S, but may transfer it

c. Data is variable and in many cases based on limited groups or on case reports

1. What do we know?

a. 22% of US population is children

b. 1.7% are reported cases (similar to China data)

c. Case breakdown =

i. 10-17 y/o = 60%

ii. 1 y/o = 15%

iii. 1-4 y/o = 11%

iv. 5-9 y/o = 15%

v. 57% males

d. Comps to adults

i. Peds experience less fever, cough, SOB -- 73% peds vs. 93% adults

ii. Hospitalization – 5.7% peds vs. 10% adults

1. Treatments?

a. Population at risk – no widespread testing, no testing for mild S/S

b. Perinatal transmission to neonates – guidelines require mandatory testing of neonates

c. Infants at higher risk than older children

d. Extrapolate treatments for adults

i. Prevention = hand washing, face masks, social distancing

ii. Behavioral changes = target stress, excessive worry, sadness, poor eating habits, unhealthy sleep habits, difficulties with attention and concentration

iii. Remdesivir – for hospital, severe disease – available for children through FDA Emergency Use Authorization OR through compassionate use program

1. Risks?

a. Standard vaccinations and wellness checks

b. PMIS-TS